Lonza Group

The Lonza Group is a Swiss multinational chemicals and biotechnology corporation with large operations in Europe, North America, and South Asia. It is headquartered in Basel. Lonza was founded in Switzerland in the late 1800s under that name. Organic, fine, and performance chemicals, bespoke manufacture of biopharmaceuticals, chemical synthesis capabilities, detection systems, and services for the bioscience sector are among the company's product development services for the pharmaceutical and biologic sectors.

Lonza makes #AHealthierWorld possible by assisting healthcare customers on the road to commercialization. Their 15,000 brilliant workers operate across a global network of more than 30 facilities to meet the needs of our clients in the pharmaceutical, biotechnology, and nutrition industries.

They assist clients produce novel and innovative medications that help cure a wide range of ailments by combining technology insight with world-class production, scientific understanding, and process excellence. They work in science, but there isn't a magic formula for how they do it. Talented individuals working together, generating commitment and ideas that assist their clients benefit others, is their most scientific answer.

Founded: 1897

Headquarters: Basel

Market Cap: 61.909 Billion USD

Website: https://www.lonza.com/